PREGNANCY OUTCOMES IN THE TOFACITINIB ULCERATIVE COLITIS OCTAVE STUDIES: AN UPDATE AS OF FEBRUARY 2020

Uma Mahadevan  ¹     Daniel C. Baumgart  ²     Marla C. Dubinsky  ³     Jesús K Yamamoto-Furusho  ⁴     Nervin Lawendy  ⁵     Gauree G. Konijeti  ⁶     Hans Peter Gröchenig  ⁷     Thomas V Jones  ⁷     nicole kulisek  ⁷     Kenneth Kwok  ⁸     Chinyu Su  ^8    
1 University of California, San Francisco, United States
² University of Alberta, Edmonton, Canada
³ Icahn School of Medicine at Mount Sinai, New York, United States
⁴ Instituto Nacional de Ciencias Médicas y Nutrición, Mexico City, Mexico
⁵ Pfizer Inc, Collegeville, United States
⁶ Scripps Clinic, La Jolla, United States
⁷ Hospital Brothers of St. John of God, St. Veit an der Glan, Austria
⁸ Pfizer Inc, New York, United States

Session
IBD (Posters)

Conference
UEG Week Virtual 2020

Citation
United European Gastroenterology Journal 2020; 8 (Supplement 1)